Abstract
A combination of chemotherapy (Cytoxan, vincristine, and CCNU) and radiation therapy was used to treat 37 patients with small-cell carcinoma of the lung. There was 49% complete remission and an overall 76% objective response with an overall median survival of 12.5 months and 17 months for those showing a complete response. No serious morbidity was observed.
MeSH terms
-
Carcinoma, Small Cell / drug therapy
-
Carcinoma, Small Cell / radiotherapy*
-
Cyclophosphamide / therapeutic use
-
Drug Therapy, Combination
-
Female
-
Humans
-
Lomustine / therapeutic use
-
Lung Neoplasms / drug therapy
-
Lung Neoplasms / radiotherapy*
-
Male
-
Middle Aged
-
Prospective Studies
-
Remission, Spontaneous
-
Vincristine / therapeutic use
Substances
-
Vincristine
-
Lomustine
-
Cyclophosphamide